Pyrrolizidine alkaloids (PAs) are the most common plant constituents that poison livestock, wildlife and humans. Riddelliine is a prototype genotoxic PA and has been nominated to be classified as a reasonably anticipated human carcinogen by the US National Toxicology Program (NTP) in the 12th Report on Carcinogens. Riddelliine's nomination is due to the high incidence of liver tumours that were observed in both mice and rats in the NTP tumourigenicity bioassay study. In this current study, we explored whether riddelliine treatment could alter microRNA (miRNA) expression in rat liver and whether the possible deregulation of miRNA was related to mutagenicity and carcinogenicity of riddelliine. Groups of six rats were administered riddelliine at a mutagenic dose of 1 mg/kg body weight or with control vehicle 5 days a week for 12 weeks. A group of six rats treated with aristolochic acid, a renal carcinogen, was used as a tissue-specific negative control. The animals were sacrificed 1 day after the last treatment and the livers were isolated for miRNA expression analysis using miRNA microarrays. miRNA expression was significantly altered by riddelliine treatment. Principal component analysis and hierarchical clustering analysis showed that the miRNA expression profiles were clearly classified into two groups, riddelliine treatment versus other samples. Forty-seven miRNAs were significantly dysregulated by riddelliine treatment, among which 38 were upregulated and 9 were down-regulated. Functional analysis of these differentially expressed miRNAs by riddelliine revealed that these miRNAs were involved in liver carcinogenicity and toxicity, such as liver proliferation, liver necrosis/cell death, hepatocellular carcinoma, liver hepatomegaly, liver inflammation and liver fibrosis. These results suggest that miRNAs actively respond to a mutagenic dose of riddelliine and the pattern of miRNA expression has the potential to be used as a biomarker of genotoxicity and carcinogenicity for riddelliine and possibly other PAs.
Introduction
Pyrrolizidine alkaloids (PAs) are present in .6000 plants worldwide (1) (2) (3) and about half of these PAs are toxic. Many PA-containing plants are poisonous to livestock and wildlife, causing tremendous livestock loss (4) (5) (6) (7) . PAs are also the leading plant toxins associated with human disease through contamination of staple foods, honey, milk, herbal teas and herbal medicines (8) . Primary liver tumours in the natives of Central Africa and South Africa have been associated with the consumption of traditional medicinal PA-containing plants (9) (10) (11) (12) . Many PA-containing plants and individual PA compounds are carcinogenic in different tissues of experimental animals, with the liver being the main carcinogenic target (13) (14) (15) (16) . PAs are mutagenic in vivo and in vitro and their mutagenicity is considered responsible for the carcinogenesis induced by PAs (17) .
Riddelliine, a heliotridine-type carcinogenic PA, has been used as a model PA to explore the toxicity, genotoxicity and carcinogenicity of PAs based on the hypothesis that different types of tumourigenic PAs induce DNA adducts, mutations and tumours with a similar mechanism (18) (19) (20) (21) . In the National Toxicology Program (NTP) tumourigenicity bioassay study, riddelliine induced a high incidence of hemangiosarcomas in rat (both sexes) and mouse (males only) liver in a dose-dependent manner (22) . In these same studies, riddelliine also induced hepatocellular adenomas and mononuclear cell leukemia in both sexes of rats and lung tumuors in female mice. Riddelliine is metabolised in the liver to two reactive metabolites, Rand S-dihydropyrrolizine, by the cytochrome P450 isozymes CYP3A and CYP2B6 (http://ntp.niehs.nih.gov/files/Riddelliine_ substance_profile_final_v3.pdf). Riddelliine is considered a genotoxic carcinogen since both the reactive metabolites can covalently bind DNA, which is likely the key step leading to DNA damage and subsequent tumourigenicity (17) . Supporting the classification of riddelliine as a genotoxic carcinogen is the fact that it has tested positive in a wide range of in vivo and in vitro genotoxicity assays. Riddelliine increased unscheduled DNA synthesis in rat liver and isolated hepatocytes (23, 24) , induced micronucleated erythrocytes in mouse and rat peripheral blood samples, produced sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary (CHO) cells (25, 26) and produced DNA mutations in the Ames test (25) and rat liver (27) . PA-signature mutations occurring in the K-ras proto-oncongene and p53 tumour-suppressor gene were found in riddelliineinduced liver tumours but not in spontaneous liver tumours (28) . These data clearly show that riddelliine is a genotoxic carcinogen in multiple species.
MicroRNAs (miRNAs) are small non-coding regulatory RNA molecules that regulate gene expression at the posttranscriptional level. Exposure to a variety of carcinogens has been shown to alter miRNA expression in both tissue-and chemical-specific manners (29) . Many of the miRNAs deregulated by carcinogens are involved in the regulation of genes that are important for every stage of chemical carcinogenesis with a large number of miRNAs functioning as putative oncogenes or tumour-suppressor genes (29) . Therefore, the altered miRNA profiles can provide new insights into the biological systems affected by chemical carcinogens and allow the dissection of molecular events in chemical carcinogenesis. In addition, due to their chemical-and tissue-specific changes in expression, miRNA profiles have the potential to be used as biomarkers for identifying the genotoxicity and carcinogenicity of chemicals.
In this study, we proposed that miRNAs were involved in response to toxicity, mutagenicity and carcinogenicity of riddelliine. To confirm our hypothesis, we determined miRNA expression profiles in liver samples from the riddelliine-treated and vehicle-control rats using microarray analysis and investigated the functions of the deregulated miRNAs through bioinformatics tools. We used the same rat liver samples as our previous mutagenic study for our evaluation of miRNA regulation by riddelliine (27) . In that study, mutant frequency was increased .3.4-fold in the livers of rats treated with 1 mg riddelliine/kg body weight. We found that the miRNA expression profiles distinguished the liver samples of riddelliine-treated animals from those of control and aristolochic acid (AA)-treated rats. Functional analysis showed that the liver miRNAs altered by riddelliine were involved in regulating genes involved in carcinogenicity and toxicity.
Materials and methods

Animal treatment
The animal treatment has been described in our previous report (27, 30) . Animal care was performed in accordance with the National Institutes of Health (NIH) 'Guide for the Care and Use of Laboratory Animals' and was authorised by the National Center for Toxicological Research (NCTR) Institutional Animal Care and Use Committee. Big Blue Fisher 344 transgenic rats were purchased from Taconic Laboratories (Germantown, NY, USA). The dose of riddelliine and treatment schedule were selected to be those associated with a clear increase in hemangiosarcomas in the NTP tumourigenicity bioassay study (26) . Groups of 6-week-old Big Blue rats were treated with 1.0 mg riddelliine/kg body weight or the vehicle by oral gavage five times a week for 12 weeks. In addition, a group of six rats treated with 10.0 mg AA/kg body weight by oral gavage five times a week for 12 weeks was used as a tissue-specific control. In a previous study, this treatment protocol for AA resulted in tumours in kidney but not in liver (31) . The rats from each treatment group were sacrificed 1 day after the last treatment. The livers were isolated, frozen quickly in liquid nitrogen and stored at À80°C.
Total RNA and miRNA isolation Frozen liver tissue was homogenised in RNA-Later ICE (Ambion Inc., Austin, TX, USA). Total RNA, including small RNA, was then isolated from the homogenate using the mirVanaä miRNA isolation kit (Ambion). Total RNA concentration was measured with a NanoDrop 1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and the quality of the total RNA was evaluated on an Agilent BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA) using an RNA6000 Nano LabChip (Agilent). The total RNA was size fractionated using an YM-100 Microcon centrifugal filter (Millipore) to obtain small RNA ,300 nucleotides.
Microarray analysis of miRNA expression The miRHumanMouseRat_12.0 miRNA microarrays obtained from LC Sciences (Houston, TX, USA) were used for this analysis. The arrays contained 349 rat miRNAs in miRBase release 12.0. The small RNA was 3#-extended with a poly(A) tail using poly(A) polymerase. After the extension, an oligonucleotide tag was ligated to the poly(A) tail for later staining with fluorescent dye Cy3. Hybridisation was performed overnight on a lParafloÒ microfluidic chip using a microcirculation pump (Atactic Technologies, Houston, TX, USA). Hybridisation images were produced using a laser scanner (GenePix 4000B, Molecular Device, Sunnyvale, CA, USA) and digitised using Array-Pro image analysis software (Media Cybernetics, Bethesda, MD, USA). Raw intensities were log 2 transformed and normalised with cyclic LOWESS (locally weighted regression). If the intensity of a miRNA in at least 1 of the 18 samples (six control, six riddelliine-treated and six AA-treated samples) was .32, the miRNA was considered detectable. Significance analysis of microarrays was performed to identify the significantly altered miRNAs. miRNAs with a false discovery rate of q , 0.001 and an absolute fold change (treatment/control) .1.5-fold were considered significantly changed and named as differentially expressed miRNAs (DEMs) hereafter.
Real-time ploymerase chain reaction confirmation of miRNA expression Six DEMs with different changes in expression level and directions of change were selected for TaqMan real-time ploymerase chain reaction (PCR) confirmation of the results from the microarray analysis. The kits for TaqMan miRNA assays were purchased from Applied Biosystems (Forster City, CA, USA). Complementary DNA was synthesised from the total RNA using genespecific primers according to the manufacture's instruction. Reverse transcriptase (RT) reactions contained 10 ng of RNA sample, 50 nM stem-loop RT primer, 1 Â RT buffer, 0.25 mM each of dNTPs, 3.33 U/ll MultiScribe reverse transcriptase and 0.25 U/ll RNase inhibitor. The reactions were performed in an Applied Biosystems 9700 Thermocycler in a 96-well plate for 30 min at 16°C, 30 min at 42°C, 5 min at 85°C and then held at 4°C. Real-time PCR was conducted according to the protocol for standard TaqManÒ PCR on an Applied Biosystems 7500 Fast Real-Time PCR System. The 10 ll of PCR reaction included 0.56 ll RT product, 1 Â TaqManÒ Universal PCR Master Mix, 0.2 lM TaqManÒ probe, 1.5 lM forward primer and 0.7 lM miRNA-specific reverse primer. The reactions were incubated in a 96-well plate at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The threshold cycle (C T ) is defined as the fractional cycle number at which the fluorescence passes the fixed threshold 0.05. The Ct data were determined using default threshold settings. The DDC T method was used for the qRT-PCR analysis to determine the relative expression of miRNAs (treatments versus control).
Principal component analysis and hierarchical clustering analysis of the miRNA expression profiles Principal component analysis (PCA) and hierarchical clustering analysis (HCA) were applied for classifying the samples based on their miRNA expression profiles to determine differences among the individual samples within ArrayTrackä, an US Food and Drug Administration-developed software package for managing, analysing and interpreting microarray gene expression data (32, 33) . The normalised intensities of detectable miRNAs were used to conduct the analyses. PCA was carried out using the autoscaled method. The normalised data were log 2 transformed prior to analysis. The eigenvalues and percentage of variability were identified and used for clustering the samples. For HCA, the distance matrix was calculated using the Euclidean method and the dendrogram was linked with an average algorithm.
Determination of target genes of the DEMs
The target genes of DEMs were identified via miRecords Version 3 for validated target genes. miRecords is an online tool for animal miRNA-target interactions (34) . The validated target genes in the miRecords database were the result of meticulous literature curation and were also experimentally validated. As of November 25, 2010, the Validated Targets database of miRecords hosts 2286 records of interactions between 548 miRNAs and 1579 target genes.
Functional analysis of DEMs' target genes
The functions relevant to the DEMs that were altered by riddelliine treatment were determined by themselves and their validated target genes. The DEMs and their target genes were analysed with Ingenuity Pathway Analysis (IPA) (http:// www.ingenuity.com/), an online functional analysis software tool that interprets the genes in the context of biological processes, pathways and molecular networks. The miRNA names and Entrez IDs of the target genes were mapped to their corresponding gene objects in the IPA Knowledge Base. These genes were then used as the starting point for generating functions. The toxicological functions related to the input genes were explored. Fisher's exact test was used to evaluate the function changes. A function was considered as significantly affected by the riddelliine treatment when its P value (Fisher's exact test) was , 0.05 and it contained more than one gene.
Results
Classification of the liver samples according to miRNA expression profiles Rats were treated with riddelliine using a protocol similar to one that resulted in liver tumours in rats (26, 35) . Six animals from the riddelliine treatment group and six animals from the vehicle treatment group as well as six rats from the AAtreatment group were sacrificed after 12 weeks of exposure and the livers were removed for miRNA microarray analysis. A total of 349 miRNAs were evaluated and 234 of them were expressed in at least one of the samples. The expressed miRNAs were normalised with cyclic lowess.
PCA and HCA were conducted to classify the samples. A PCA 3D view using the first three principal components for the miRNA expression profiles is displayed in Figure 1A and the grouping of the samples according to the miRNA expression is shown in Figure 1B . In the PCA plot, the six riddelliine samples were grouped together and were well separated from the six control and six AA-treated samples. HCA also revealed distinct grouping of these samples into two main branches, riddelliine treatment versus other samples. Animal AA_6 formed a third branch, with the pattern of miRNA expression clearly different than all the riddelliinetreated animals. This same animal was the outlying animal in the PCA plot (purple dot outside of dashed circles).
Liver miRNA expression altered by riddelliine The DEMs were determined using a criterion of q , 0.001 and fold changes .1.5. A total of 47 and 4 miRNAs of 234 detectable miRNA were differentially expressed by treatment of riddelliine and AA, respectively (Table I) . Two DEMs, miR34a and miR-125b-5p, are common in the two lists. Among the 47 riddelliine-induced DEMs, 38 were up-regulated and 9 were down-regulated. The up-regulated DEMs whose changes were .3-fold include eight miRNAs: miR-101a, miR-29b, miR-505, miR-19b, miR-30e, miR-34a, miR-152 and miR-7a*, while the DEM whose fold change was ,3-fold had only one, miR-329. TaqMan real-time PCR was used to confirm the microarray expression results for six miRNAs. In general, the real-time PCR measurements were consistent with the miRNA microarray findings (Table II) .
Functional analysis of the riddelliine-induced DEMs miRNAs function through binding to the 3#-untranslated region of their target genes' mRNA, inhibiting the translation of the mRNA and ultimately down-regulating gene expression (36) . Therefore, miRNAs' functions are related to their target genes. One approach for miRNA functional analysis is to explore miRNAs' validated or predicted target genes. In this study, validated target genes of DEMs were utilised to explore the DEMs' role in riddelliine-induced toxicity and carcinogenicity. A total of 193 target genes of these riddelliine-induced DEMs were found (supplementary Table 1 , available at Mutagenesis Online). Some target genes are regulated by multiple miRNAs, while multiple genes are targeted by a single miRNA. For example, the vascular endothelial growth factor (Vegf) gene is the target of five different miRNAs (miR-150, miR-93, miR-34a, miR-17 and miR-106b), while miR-34a targets 21 different genes (supplementary Table 1 , available at Mutagenesis Online). Therefore, functional analysis of the DEMs was conducted by analysing all the target genes together.
The 193 mRNA target genes were input into the IPA database for functional analysis. The analysis results showed that the major functions related to the target genes of the DEMs are associated with the carcinogenicity and toxicity of riddelliine in rat liver (Table III) . The top three functions are liver proliferation, liver necrosis/cell death and hepatocellular carcinoma, which are closely related to PA-induced carcinogenesis. The miRNA target genes were also closely associated with liver toxicity of PA such as liver hepatomegaly, liver inflammation and liver fibrosis.
Discussion
miRNA profiles distinguish riddelliine exposure in rat liver
In this study, we demonstrated an association between liver miRNA expression patterns and carcinogen treatment. The miRNA profiles generated from the microarray analysis are surprisingly informative and reflect the hepatic carcinogenicity potential of the test articles. Both PCA and HCA showed that miRNA expression profiles of riddelliine-treated samples were different from other samples while the expression profiles between control and AA-treated samples were not different (Figure 1) . Also, there were a large number of DEMs between the riddelliine-treated and control samples, while there were miRNA expression altered by riddelliine in rat liver only a few DEMs between AA-treated and control samples ( Table I) .
The large number of miRNAs dysregulated by riddelliine treatment might reflect the carcinogenicity of riddelliine in rat liver. Other studies showed that carcinogen treatment resulted in altered expression of a large number of miRNAs in the target organ, with up-regulation of most DEMs (29) . For example, comfrey, a carcinogenic plant, induced 45 DEMs, 29 of which were up-regulated in rat liver (37) ; N-ethyl-N-nitrosourea, an alkylating carcinogen, significantly deregulated 32 miRNAs with 28 up-regulated in rat liver (38) and tumourigenic conazoles induced many more changes in miRNA expression than a non-tumourigenic conazole in mouse liver (39) .
AA treatment was used as a tissue-specific control in this study. Both riddelliine and AA are carcinogens; however, they target different tissues, with riddelliine and AA targeting the liver and kidney, respectively (31, 40) . Our previous study showed that AA treatment significantly altered the global expression of kidney miRNAs and resulted in many DEMs (41) . In the present study, AA treatment resulted in only four DEMs in the liver, which is not surprising since liver is not a target organ. It appears that miRNA expression profiles are more specific to carcinogenic insult than mRNA profiles. Previous work showed that mRNA expression profiles could distinguish the carcinogenic effects of AA in rat kidney; however, many differentially expressed genes were also found SD stands for standard deviation; fold change is calculated by dividing the treatment mean value by the control mean value.
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in the liver (42) . The affected genes in the liver were mainly associated with changes of lipid metabolism, one of the pharmacodynamic actions of AA. In contrast, in the present study, the miRNA expression profiles in the liver were not dramatically changed by AA treatment with only four DEMs after treatment. The miRNA expression patterns in rat kidney and liver after AA treatment suggest that miRNA expression is specific to the target organ of the carcinogen. In contrast, mRNA expression may be altered in non-target organs by noncarcinogenic effects of the test article.
DEMs and their targeted genes are associated with the carcinogenicity of riddelliine In this study, we used liver tissue samples from the same animals for which mutation induction and gene expression changes have been previously reported (27, 43) . Using the same 
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miRNA expression altered by riddelliine in rat liver
samples is important since it shows that the dose of riddelliine used in this study induced clear mutagenic changes, which are precursors to carcinogenicity. Therefore, changes in miRNA expression can be linked to the carcinogenic effects of riddelliine in rat liver. The rats were treated with a mutagenic dose of riddelliine for 12 weeks. Previous studies showed that the similar treatments had resulted in liver toxicity, liver DNA adduct formation, mutation induction and an early stage of tumour development. The body weight gains of the treated animals were decreased at this time point. Serum activities of alkaline phosphatase and sorbitol dehydrogenase increased.
The most significant treatment-related histopathological lesions occurred in the liver including hepatocyte cytomegaly and karyomegaly, cytoplasmic vacuolisation, centrilobular necrosis, mixed inflammatory cell infiltration and bile duct hyperplasia. Increases in unscheduled DNA and S-phase syntheses were detected in primary hepatocytes from the treated rats. The treatment also resulted in a set of eight dehydroretronecine-derived DNA adducts in rat liver. Threefold more mutant frequency over the background in the cII gene was induced by the riddelliine treatment. High frequency of G:C / T:A transversion and tandem base substitutions of GG / TT and GG / AT were found to be the signature of mutations induced by riddelliine. Adenomas in the liver of rats also were found in the treated animals although they occurred at a low frequency (13, 25, 27, 44) . Longer term treatment of Fisher 344 rats at the same dose eventually induced high incidence of liver tumours (22, 26) . If miRNAs are involved in riddelliine carcinogenesis, the miRNA expression changes at 12 weeks (prior to tumour formation) should reflect the early events of carcinogenesis including DNA adduct formation, genetic disorders, mutation induction, tumour initiation and cancer development. According to our analysis using IPA, $36 of the 47 DEMs are eligible for biological network analysis and 27 of them are eligible for pathway and function analysis. The main associated network functions with the 36 miRNAs are cancer, genetic disorder, cell cycle, cellular growth and proliferation, cellular development and hepatic system disease. Among the 27 miRNAs associated with different functions, 21 are related to cancer, 20 to genetic disorder, 15 to cellular growth and proliferation and 7 to hepatic system disorder (supplementary Table 2 , available at Mutagenesis Online). The identified main hepatotoxicities related with these miRNAs are hepatocellular carcinoma and liver fibrosis. Thus, these DEMs clearly play a role in the toxicity and carcinogenicity of riddelliine in rat liver.
The majority of the DEMs (30 of 47) identified in this study have also been reported to be deregulated by other carcinogen exposures (29) . Our data on these DEMs are consistent with published studies that provide evidence for alteration in miRNA expression in response to carcinogen insults, especially for miR34a whose expression was significantly increased by riddelliine treatment. miR-34a is expressed at high levels in most tissues exposed to genotoxic carcinogens (37, (45) (46) (47) (48) (49) (50) while it is expressed at low levels in tumours (51, 52) . miR-34a is considered a tumour-suppressor miRNA and it is directly regulated by p53 protein. When the p53 gene is activated by genotoxic agents, p53 will bind to the promoter region of miR34a and up-regulate miR-34a expression. Ectopic miR-34a expression can induce apoptosis, cell cycle arrest and DNA repair. The loss of miR-34a expression has been linked to resistance against apoptosis induced by p53-activating agents used in chemotherapy (52, 53) . miR-34a was also up-regulated in rat liver by a dose of AA that resulted in kidney but not liver tumours. Although liver is not an AA target tissue, AA did induce DNA adducts and mutations in rat liver (54) . Therefore, miR-34a might be a biomarker of genotoxin exposure, regardless of the ultimate target organ.
To further explore the functions of the DEMs, their 193 validated target genes were functionally analysed. The top relevant functions related to these target genes are liver proliferation, liver cell death, hepatocellular carcinoma, liver hepatomegaly, liver steatosis, liver adhesion and liver cirrhosis (Table III) . These functions are correlated to previously reported liver injury, DNA adduct formation, mutation induction and tumour formation caused by riddelliine exposure (13, 25, 27, 44) , suggesting miRNAs regulated their target genes in response to the hepatotoxic insults of riddelliine. Among these target genes, 21 of them are regulated by miR-34a. Most of the miR-34a target genes are involved in P53-related functions, such as apoptosis and DNA repair. For example, miR-34a suppression of Strt1 expression can lead to an increase in acetylated P53. As a result, miR-34a inhibition of SIRT1 ultimately leads to P53-mediated apoptosis (55) . Other exemplary protein downregulations were confirmed for CDK4/6, Cyclin E2, E2F, MET and Bcl-2 (53, 56, 57) . Suppression of these proteins will lead three cellular events, namely G1 arrest, apoptosis and senescence.
Potential miRNA signature for PAs Previously, we reported the miRNA expression profiles induced by comfrey, a PA-containing plant (37) . Because all toxic PAs are metabolically activated by cytochrome P450 enzymes to form common esters that are the primary metabolites for the genotoxicity and carcinogenicity, PAs exert their toxic effects by similar mechanisms (17, 58) . PAs generally produce the same types of DNA adducts (58) and both comfrey and riddelliine have similar mutational spectra and gene expression patterns (59) (60) (61) . Comparison of the miRNAs altered by both comfrey and riddelliine treatments could provide valuable information about common mechanisms of PAs and find potential miRNA signatures that could be used as predictive biomarkers of PA genotoxicity.
There are 20 common DEMs that were altered by both comfrey and riddelliine (Table IV) . Of these, the direction of change in expression was the same except for one, miR-200b. The DEMs that were not shared by both compounds are likely due to the different properties of the two chemicals including differential pharmacological and toxicological effects. For the 19 common DEMs with same direction of change, the probability of this concordance occurring by chance is extremely small (P , 0.0001). In addition, both comfrey and riddelliine triggered miRNA expression changes associated with cancer, cell death and other functional processes in rat liver. Therefore, for the common miRNAs altered by both riddelliine and comfrey, it is likely that they represent a common mechanism(s) of carcinogenesis. Thus, this pattern of miRNA expression comprises a potential signature for PA carcinogenic effects.
Summary
Treatment with a mutagenic dose of riddelliine resulted in the alteration of miRNA expression in rat liver, the target organ. The samples were classified according to their miRNA expression profiles. Liver samples from riddelliine-treated rats were separated from the control and AA-treated rats. Fortyseven miRNAs were significantly differentially expressed by riddelliine treatment, with most of them up-regulated. Functional analysis of these DEMs and their target genes revealed that the alteration of miRNA expression was related to the liver carcinogenicity of PA, such as cancer, liver proliferation, liver necrosis/cell death, liver inflammation and liver fibrosis. A comparison of miRNA expression profiles induced by comfrey and riddelliine in rat liver showed a set of 19 common DEMs that could have the potential to be used as a biomarker of genotoxicity and carcinogenicity caused by PAs and PAcontaining plants.
Supplementary data
Supplementary Tables 1 and 2 are available at Mutagenesis Online. Comfrey data are from literature (37) .
